MoneyWorks4Me

Panacea Biotec informs about updates

28 Oct 2023 Evaluate

Panacea Biotec has informed that about the launch of Paclitaxel Protein-Based Particles for Injectable Suspension (Albumin - Bound), a generic version of Abraxane in the Canadian market by its material wholly-owned subsidiary company viz. Panacea Biotec Pharma through its strategic partner Apotex Inc., Canada.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..